NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J
Format:	Journal article
Idioma:	English
Publicat:	Termedia Publishing House Ltd. 2009

Ítems similars

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
per: Amandeep Aujla, et al.
Publicat: (2019-04-01)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
per: Ali Ghassemi, et al.
Publicat: (2016-06-01)

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
per: Miguel Enrique Cuéllar Mendoza, et al.
Publicat: (2024-02-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
per: Betül Sevinir, et al.
Publicat: (2011-03-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
per: Betül Sevinir, et al.
Publicat: (2011-03-01)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
per: Seth E. Karol, et al.
Publicat: (2021-07-01)

NK cell compartment in patients with coronary heart disease.
per: Hak, Ł, et al.
Publicat: (2007)

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
per: Darshana Jani, et al.
Publicat: (2018-02-01)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
per: Škorić Biljana, et al.
Publicat: (2020-01-01)

Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
per: Marlise R. Luskin, et al.
Publicat: (2025-02-01)

Changes in number of NK cells after one year from coronary artery bypass graft
per: Hak, L, et al.
Publicat: (2009)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
per: Mariam M. Bhuiyan, et al.
Publicat: (2018-06-01)

Linfoma No Hodgkin extranodal NK/T nasal Extranodal Non-Hodgkin NK/T nasal Lymphoma
per: Enrique Muñoz Hernández, et al.
Publicat: (2019-05-01)

Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
per: Gustavo de Oliveira Canedo, et al.
Publicat: (2025-02-01)

TO THE PROBLEM OF RADIATION-INDUCED CARCINOGENESIS AFTER TREATMENT OF HODGKIN’S LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS
per: O. I. Scherbenko, et al.
Publicat: (2016-02-01)

Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia
per: Le Jie Lee, et al.
Publicat: (2022-01-01)

The importance of intensive chemotherapy for advanced Hodgkin lymphoma in children
per: E.S. Belyaeva, et al.
Publicat: (2020-06-01)

NK cell compartment in patients with coronary heart disease
per: Siebert Janusz, et al.
Publicat: (2007-05-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
per: Andrew D. Hughes, et al.
Publicat: (2025-01-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
per: Luke Maese, et al.
Publicat: (2022-06-01)

Combination chemotherapy for Hodgkin lymphoma
per: Alison J. Moskowitz
Publicat: (2024-08-01)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
per: Sonal Jain, et al.
Publicat: (2014-08-01)

The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cell Lines
per: Marta Woźniak, et al.
Publicat: (2021-04-01)

Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma
per: Jiwei Song, et al.
Publicat: (2022-08-01)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
per: Andreas Engert, et al.
Publicat: (2017-12-01)

Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy
per: Ling Ling Chua, et al.
Publicat: (2020-02-01)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
per: Siba El Hussein, et al.
Publicat: (2023-11-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
per: Ardeshir Ghavamzadeh, et al.
Publicat: (2012-04-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
per: Taher Entezari-Maleki, et al.
Publicat: (2012-06-01)

Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
per: Keyu Liu, et al.
Publicat: (2018-01-01)

Genetic Variations of Tumor Necrosis Factor –α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients
per: Hajar Nasiri, et al.
Publicat: (2013-09-01)

Hyperglycemia during induction chemotherapy of pediatric acute lymphoblastic leukemia
per: Shwetha Seetharam, et al.
Publicat: (2016-01-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
per: Awais Arshed, et al.
Publicat: (2022-11-01)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy
per: Zhao J, et al.
Publicat: (2015-06-01)

Participation in Physical Activity and Physical Education in School Among Children With Acute Lymphoblastic Leukemia After Intensive Chemotherapy
per: Hamidah Alias, et al.
Publicat: (2019-03-01)

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma
per: Stefan Lozenov, et al.
Publicat: (2024-09-01)

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia
per: Mako Ikeda, et al.
Publicat: (2023-01-01)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
per: Linu A Jacob, et al.
Publicat: (2015-01-01)

Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma
per: Baldeep Wirk
Publicat: (2010-01-01)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
per: Guillermo eGervasini, et al.
Publicat: (2012-11-01)